Apellis Pharmaceuticals Inc (APLS)
30.77
+3.02
(+10.88%)
USD |
NASDAQ |
Nov 22, 16:00
30.76
-0.01
(-0.03%)
After-Hours: 20:00
Apellis Pharmaceuticals Free Cash Flow: -205.58M for Sept. 30, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| September 30, 2024 | -205.58M |
| June 30, 2024 | -408.81M |
| March 31, 2024 | -550.90M |
| December 31, 2023 | -595.51M |
| September 30, 2023 | -639.13M |
| June 30, 2023 | -624.61M |
| March 31, 2023 | -581.50M |
| December 31, 2022 | -515.27M |
| September 30, 2022 | -486.19M |
| June 30, 2022 | -500.56M |
| March 31, 2022 | -522.08M |
| December 31, 2021 | -564.23M |
| September 30, 2021 | -310.44M |
| June 30, 2021 | -245.03M |
| Date | Value |
|---|---|
| March 31, 2021 | -210.92M |
| December 31, 2020 | -165.91M |
| September 30, 2020 | -389.40M |
| June 30, 2020 | -339.91M |
| March 31, 2020 | -285.18M |
| December 31, 2019 | -212.83M |
| September 30, 2019 | -173.54M |
| June 30, 2019 | -153.08M |
| March 31, 2019 | -143.87M |
| December 31, 2018 | -131.24M |
| September 30, 2018 | -102.30M |
| June 30, 2018 | -80.30M |
| March 31, 2018 | -61.10M |
| December 31, 2017 | -46.60M |
Free Cash Flow Range, Past 5 Years
-639.13M
Minimum
Sep 2023
-165.91M
Maximum
Dec 2020
-417.70M
Average
-447.50M
Median
Free Cash Flow Benchmarks
| Biomarin Pharmaceutical Inc | 300.88M |
| Ionis Pharmaceuticals Inc | -374.21M |
| EyePoint Pharmaceuticals Inc | -118.04M |
| Cassava Sciences Inc | -78.07M |
| Macrogenics Inc | -61.71M |